New Alzheimer's Care Developments Hit Little Rock
Arkansas residents learn about new biomarker testing and support options for early-stage Alzheimer's.
Updated on Oct. 22, 2026 in Alzheimer’s
Live Poll
Do you feel there is sufficient support available for families caring for relatives with Alzheimer's?
The Alzheimer's Foundation of America recently hosted an educational conference in Little Rock to discuss treatment advancements and the persistent shortage of dementia caregivers in Arkansas. With over 60,000 state residents currently living with the disease, experts emphasized both new diagnostic tools and local support challenges.
Why it matters
As Alzheimer's remains the sixth-leading cause of death in the United States, improvements in early detection via biomarker testing are changing how clinicians approach the disease. However, rural areas like Arkansas face significant barriers to care due to medical staffing shortages and funding constraints.
Public health data shows that more than 60,000 people in Arkansas and 7 million across the U.S. live with Alzheimer's disease. While 2025 saw the introduction of plasma-based biomarker testing for those 55 and older, the efficacy of scaling these diagnostics in rural regions remains unresolved.
The players
Alzheimer's Foundation of America
A national nonprofit organization that provides support services and education for individuals living with Alzheimer's disease and their families.
FDA
The federal agency responsible for protecting public health by ensuring the safety and efficacy of human drugs and biological products.
The details
Diagnostic advancements now focus on identifying core biomarkers, which may appear up to 20 years before symptoms become clinically evident. Meanwhile, therapeutic options have expanded with the FDA approval of medications such as Leqembi and Kisunla for early-stage patients. Despite these medical gains, the local care infrastructure struggles as agencies on aging face worker shortages driven by low wages and limited Medicaid reimbursements.
Timeline
Wednesday: The Alzheimer's Foundation of America conference occurred in Little Rock.
2004: Barbara Broyles died of Alzheimer's disease.
2017: Frank Broyles died of Alzheimer's complications.
2025: Biomarker testing for individuals aged 55 and older gained approval.
Health Landscape
The medical standard for Alzheimer's is shifting from late-stage symptom management to identifying core biomarkers years before impairment. This evolution marks a departure from historic approaches, though widespread implementation remains constrained by rural workforce shortages.
If you are 55 or older and experiencing cognitive concerns, it is worth discussing the availability of newer biomarker tests with your physician. Caregivers in Arkansas should consult their local area agency on aging regarding available grant-funded assistance for medical appointments.
The takeaway
Early detection via biomarker testing is becoming a reality, yet care coordination remains a significant hurdle for many families. If you are concerned about cognitive health, talk to your doctor about early screening options and contact your regional agency on aging for support resources.
Further reading
For more on managing care and understanding symptoms, visit our Alzheimer’s section.
Source note: This article includes information reported by Northwest Arkansas Democrat Gazette.
Live Poll
Do you feel there is sufficient support available for families caring for relatives with Alzheimer's?
